Table 1_A mobile app compared with an educational pamphlet on menopause hormone therapy initiation: a randomized pilot study.docx

Baseline and post-visit surveys were collected assessing patient experience, engagement, and perceived usefulness. Rates of menopause hormone therapy (HT) prescribing were compared with a reference population of nonparticipants aged 45–55 who had a primary care appointment at Mayo Clinic during the same period and received no study education materials.</p>Key results<p>Of 653 participants enrolled and randomized, 383 completed both the baseline and post-surveys (171 intervention and 212 control).

HT initiation among study participants was significantly higher than in the reference population of women (9.3% vs. 4.4%, p < 0.001). There was no difference in HT initiation between the intervention (9.1%) and control groups (9.6%) (p = 0.83). Initiation rates were 3.8% and 4.5%, respectively (p = 0.64) for nonhormone therapies.</p>Conclusions<p>Among women with bothersome menopause symptoms, those who underwent previsit symptom screening and received educational materials had higher rates of HT initiation than women who did not participate in the study.

These findings suggest that structured menopause education may improve recognition and management of menopause symptoms in routine clinical practice.</p>